Skip to main content

Table 2 Proportion of patients receiving each of the 17 most common first antibiotic regimens

From: Variation in antibiotic treatment for diabetic patients with serious foot infections: A retrospective observational study

 

Overall

Cellulitis and

Gangrene

Cellulitis and

Osteomyelitis

Cellulitis and

Ulcer

Cellulitis Only

 

(n = 2248)

(n = 894)

(n = 503)

(n = 644)

(n = 207)

 

Observed Proportion (Range*) %

Piperacillin-tazobactam

16.4

(22.8)

20.1

(23.9)

14.7

(24.2)

14.9

(14.2)

8.7

(11.5)

Piperacillin-tazobactam, Vancomycin

15.7

(36.1)

16.1

(33.9)

18.1

(58.3)

15.4

(21.8)

9.7

(11.3)

Ampicillin-sulbactam

10.8

(50.5)

11.3

(42.5)

10.7

(48.8)

9.5

(30.7)

12.6

(21.4)

Vancomycin

6.9

(13.5)

6.2

(6.1)

9.1

(21.1)

5.7

(7.0)

7.7

(13.8)

Cefazolin

4.2

(12.6)

3.4

(9.2)

3.2

(19.7)

5.6

(14.4)

6.3

(12.1)

Amoxicillin-clavulanate§

2.0

(3.3)

1.5

(4.1)

0.6

(10.9)

3.7

(7.3)

2.4

( - )

Ticarcillin-clavulanate

2.0

(48.6)

1.9

(41.6)

1.6

(40.6)

2.5

(43.1)

1.9

( - )

Cephalexin§

1.6

(7.3)

0.8

(4.6)

0.8

(26.2)

2.2

(10.1)

4.8

(12.7)

Ertapenem

1.4

(14.9)

1.0

(11.5)

2.6

(19.9)

0.5

(12.1)

1.0

( - )

Ciprofloxacin§

1.3

(2.5)

1.2

(6.1)

1.4

(6.1)

1.6

(7.9)

0.5

( - )

Ampicillin-sulbactam, vancomycin

1.2

(3.0)

1.2

(2.7)

1.4

(17.4)

1.1

(3.7)

1.0

( - )

Imipenem

1.2

(4.3)

2.1

(11.5)

0.8

(24.9)

0.3

( - )

1.0

( - )

Ceftriaxone

1.2

(3.8)

0.8

(3.7)

1.4

(6.2)

1.6

(6.9)

1.0

( - )

Ciprofloxacin, clindamycin

1.1

(12.7)

1.5

(21.1)

0.6

(15.6)

0.8

(2.9)

1.4

( - )

Clindamycin

1.1

(3.6)

1.1

(7.2)

0.8

(9.7)

0.8

(10.8)

2.4

( - )

Gatifloxacin§

1.1

(4.1)

0.4

(8.1)

1.2

(3.9)

1.9

(23.7)

1.0

( - )

Nafcillin

1.1

(2.8)

0.6

(6.5)

1.4

(7.9)

1.1

(25.1)

2.4

( - )

  1. * Statistic uses shrunken hospital rates (see methods)
  2. § Given orally
  3. ( - ) No range